SmokeFreeNZ: Designing and Evaluating the Effectiveness of a Mobile Application in Reducing Cigarette Consumption
Files
Date
2018-10
Citation
Wu, L., Stamp, D., Hanlon, E., Hampton, J., Mercier, J., Hicks, K., Baghaei, N., Casey, J. and Su, B. (2018) ‘SmokeFreeNZ: Designing and Evaluating the Effectiveness of a Mobile Application in Reducing Cigarette Consumption’, Journal of Clinical and Medical Sciences, 2(1), p. 108. Available at: https://www.walshmedicalmedia.com/open-access/smokefreenz-designing-and-evaluating-the-effectiveness-of-a-mobile-application-in-reducing-cigarette-consumption.pdf.
Abstract
Background: Smoking is one of the leading causes of mortality and morbidity in New Zealand and the greatest
burden of disease in the health of New Zealanders. A novel mobile application, SmokeFreeNZ, was developed for
android phone systems.
Objective: To investigate the efficacy of the SmokeFreeNZ app on prevalence of abstinence, self-reported
number of cravings per day and smoking knowledge index measures.
Methods: Forty Unitec smokers (30 android users and 10 controls) were recruited. Smokers’ demographics and
their smoking information were investigated at baseline. The efficacy of the mobile app was evaluated by measuring
prevalence of abstinence, self-reported number of cravings per day and smoking knowledge index measures.
Results: After the mobile app use, mean Smoking Knowledge Index Measures increased from 62 (± 9)% to 96 (±
3)% (p<0.001) compared to the control group. Maximum number of days of continuous abstinence was 5.2 (± 0.5)
days in the app user group and 2.1 (± 0.5) days in the control group (p<0.02). The prevalence of seven days
abstinence in users of SmokeFreeNZ was also improved significantly in comparison to the control group (26.7% in
the app user group compared to 10.0% in the control group, Chi-square tests; p<0.05). These findings indicate that
the SmokeFreeNZ app did help smokers at Unitec to quit smoking.
Conclusion: The SmokeFreeNZ app provided flexible and effective approach to coach smokers about the health
risks of smoking and also improved seven days’ abstinence rates in the study period. Future investigation is required
to compare the cost-benefit effects and to evaluate the efficacy in smoking cessation in a larger-scale trial.